Home >> News >> Genomics Market Expected To Exhibit Rapid Growth During The Forecast Period

Genomics Market Expected To Exhibit Rapid Growth During The Forecast Period

The latest market report published by Acute Market Reports “Genomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global genomics market was valued at US$ 13,122.9 Mn in 2017 expanding at a CAGR of 10.3% from 2018 to 2026.

Market Insights

Genomics is the study of genetic coding of an organism and projected to play a vital role in management of disease conditions in the future. Genomics has proved fruitful in diagnosis and prognosis of various chronic and congenital diseases. For instance, its application in BRCA1 mutation identification has been gold standard in cancer research and treatment. The idea of whole genome sequencing is becoming a common practice owing to precision medicine trends, investments and favorable collaborations between industry participants and regulatory authorities. The Precision Medicine Initiative (PMI) in the U.S. aims to collect database of health data of 1 million volunteers including genetics and lifestyle factors. In the U.K., Genomics England aims to sequence 1 million genome from patients with various diseases from different genomic medicine centers. Many pharmaceutical companies such as GSK, Roche, and AstraZeneca have ventured in the GENE Consortium in Europe giving them access to database of 5,000 sequenced genomes. Ireland, Iceland and China are some of the other countries that have launched their private programs to gain a better understanding in personalized medicine and genomics in clinical application. However, concerns regarding the security and privacy of the information, high cost of programs are some of the challenging factors of this market.

Browse the full report at https://www.acutemarketreports.com/report/genomics-market

In terms of application type, disease diagnostics held the largest share in the global genomics market. Molecular diagnostics companies such as Pathway Genomics, Myriad Genetics, Quest Diagnostics, and Abbott Laboratories actively collecting genomics data from different groups of patients. These companies provide diagnostic kit as well as technological products used for the genomic processes. Growing preferences of molecular diagnostics and point-of-care diagnostics have further driven the growth of disease diagnostics market. Personalized medicine and drug discovery application are poised to grow at a significant rate during the forecast period. In terms of end-user, biopharmaceutical companies held the largest share in the market due to growing number of research studies carried out for drug discovery and development purposes and personalized medicine.

In terms of geography, North America held the largest share in the global genomics market owing to domicile of major biotechnology and pharmaceutical companies in the region. The Unites States lead the North America genomics market owing to strong governmental support and funding for genomic research. The U.S. is the foremost country in cancer and other chronic disease research. Growing awareness regarding the genetic testing and high affordability of such tests in the country make U.S. the most attractive market for genomics. Europe held the second largest share in the genomics market owing to developed genomics industry in the region, particularly in U.K., Germany and France. Asia Pacific is projected to grow at fastest rate during the forecast period. Factors responsible for the growth of this market include growing research and development of genomic technologies, biomarkers testing in treatment of various diseases. China has emerged as the leader in genomics solutions with significant contribution in the global genomics market. China’s genomics program includes 1 million genomes sequencing for specific cancer and metabolic disease detection.

The key players currently engaged in genomics market include:

• Thermo Fisher Scientific, Inc.
• Bio-Rad Technologies, Inc.
• Illumina, Inc.
• Danaher Corporation
• Pacific Biosciences
• Oxford Nanopore Technologies.
• Myriad Genetics, Inc.
• Others

Key Market Movements:

• Growing R&D and funding for genomics in clinical application
• Growing private and governmental collaborations for genomics programs
• Increasing applications of genomic studies agriculture and veterinary research
• Robust growth of genomic studies in Asia Pacific, especially in China, South Korea and India

The Global Genomics Market is Segmented into:

Research Period  2016-2026
Base Year 2017
Forecast Period  2018-2026
Historical Year  2016
Unit  USD Million
Segmentation  By Product & Services Type (2016–2026; US$ Mn)
 By Application (2016–2026; US$ Mn)
 By End-User (2016 – 2026; Mn)
 Geography Segment (2016–2026; US$ Mn)

*Complete segmentation list is on report page


About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
(US/CANADA) Ph.: +1-855-455-8662

Leave a Reply

Your email address will not be published. Required fields are marked *